Location: Home
  • search
  • go
  • Relate News
  • 4/15/2026China's Pharma Innovators Pursue a Range of Deal Structures to Support...
  • 4/15/2026Immorna Reports FIC Clinical Signal for In Vivo CAR-T in Systemic Scle...
  • 4/15/2026Shanghai Minwei's Triple Agonist MWN109 Shows Strong Early Weight-Loss...
  • 4/14/2026China Moves to Strengthen Community Healthcare and Expand Rehabilitati...
  • 4/14/2026China Unveils New Drug Pricing Reform to Balance Innovation, Affordabi...
  • 4/14/2026PhRMA Warns U.S. Drug Pricing Policies Could Accelerate China's Rise i...
  • 4/13/2026China Outbound Biopharma Licensing Surges as Global Demand for Innovat...
  • 4/13/2026How Big Pharma's China Trials Are Escaping Scrutiny (The Wire China)
  • 4/13/2026BeOne Secures China Conditional Approval for Imdylltra in Third-Line E...
  • 4/13/2026AstraZeneca's Imjudo Wins China Approval, Likely for First-Line EGFR/A...
  • 4/13/2026Oculgen Launches Global Phase II/III Trial of OCUL101 in Wet AMD
  • 4/13/2026GenScript Partners With Mimulus to Industrialize DNA Data Storage for ...
  • 4/13/2026BioNTech and DualityBio Report Positive Registrational Phase 2 Results...
  • 4/10/2026IMPACT Thera Secures $5M Milestone as PARP1-Selective IMP1734 Advances...
  • 4/10/2026China Unveils Sweeping Measures to Accelerate Tiered Healthcare System...
  • 4/10/2026NHSA Launches First Public Disclosure for Reference Drug Pre-Communica...
  • 4/9/2026Everest Medicines to Acquire Hasten's Asia-Pacific Platform in $250M ...
  • 4/9/2026GSK Wins China Approval for Exdensur in Chronic Rhinosinusitis With Na...
  • 4/9/2026Over Half of China-Listed Drugmakers Grow 2025 Profit as Innovation an...
  • 4/9/2026China's Innovative Drug Out-Licensing Surge Tops CNY 400B in Q1 as Gl...
  • 4/9/2026China Backs Independent Pricing for Innovative Drugs in Landmark State...
  • 4/8/2026Global Drugmakers Brace for Another Tough China Year as Beijing Intens...
  • 4/8/2026Merck and Zhifei Shift to Demand-Based China Vaccine Supply Model as G...
  • 4/8/2026NMPA Adopts ICH M14 Guideline, Expanding China's Regulatory Framework ...
  • 4/7/2026Adagene, Incyte Launch Clinical Collaboration to Advance Novel MSS Col...
  • 4/7/2026Kelun-Biotech and HBM's Atopic Dermatitis Bispecific Revealed as TSLP/...
  • 4/7/2026Bayer Deepens China Innovation Push as Pharma Division Targets 30% Mar...
  • 4/7/2026Pharma Bets Big on Chinese Drugmakers (The Wire China)
  • 4/3/2026China's $13B Pharma Boom Drives Growth But Faces Hurdles in US and EU ...
  • 4/3/2026Yifan/Evive Expands Ryzneuta Europe Footprint With France Licensing De...
  • Page:3/386 Total number of articles:11579: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group